Mepron and Combivir drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Mepron (atovaquone) and Combivir (lamivudine; zidovudine). Common drug interactions include osteoporosis among females and fatigue among males.

The phase IV clinical study analyzes what interactions people have when they take Mepron and Combivir. It is created by eHealthMe based on reports of 56 people who take the same drugs from the FDA, and is updated regularly.

What is Mepron?

Mepron has active ingredients of atovaquone. It is often used in babesiosis. eHealthMe is studying from 2,091 Mepron users. Check the latest studies of Mepron.

What is Combivir?

Combivir has active ingredients of lamivudine; zidovudine. It is often used in hiv infection. eHealthMe is studying from 15,450 Combivir users. Check the latest studies of Combivir.



On Jul, 27, 2026

56 people who take Mepron and Combivir together, and have interactions are studied.

Mepron and Combivir drug interactions.

What are the common drug interactions of Mepron and Combivir, by gender? *:

female:

  1. Osteoporosis (bones weak and more likely to break)
  2. Bone loss
  3. Chronic kidney disease
  4. Nausea (feeling of having an urge to vomit)
  5. Osteonecrosis (death of bone)
  6. Post-traumatic stress disorder
  7. Rash
  8. Deafness
  9. Depression
  10. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)

male:

  1. Fatigue (feeling of tiredness)
  2. Dyspnoea (difficult or laboured respiration)
  3. Premature baby
  4. Renal failure acute (rapid kidney dysfunction)
  5. Blood bilirubin increased
  6. Acute respiratory failure
  7. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  8. Anxiety
  9. Bone marrow failure
  10. C-reactive protein increased

What are the common drug interactions of Mepron and Combivir, by age (0-1 to 60+)? *:

0-1:

  1. Cardiac murmur (an heart sound in valve abnormality)
  2. Foetal exposure during pregnancy (exposing your unborn child to contraindicated in pregnancy leads birth defect)
  3. Premature baby

2-9:

n/a

10-19:

n/a

20-29:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Anxiety
  3. Emotional distress
  4. Pain
  5. Rash
  6. Chronic kidney disease
  7. Depression
  8. Nausea (feeling of having an urge to vomit)
  9. Post-traumatic stress disorder
  10. Decreased activity

30-39:

  1. Pleural effusion (water on the lungs)
  2. Pulmonary haemorrhage (acute bleeding from the lung)
  3. Respiratory distress (difficulty in breathing)
  4. Blood sodium decreased
  5. Cardio-respiratory arrest (sudden dysfunction of heart and lungs)
  6. Tachycardia (a heart rate that exceeds the range of 100 beats/min)
  7. Alanine aminotransferase increased
  8. Anaemia (lack of blood)
  9. Blood chloride decreased
  10. Bone marrow disorder

40-49:

  1. Arthritis (form of joint disorder that involves inflammation of one or more joints)
  2. Bone density decreased
  3. Chronic kidney disease
  4. Osteoarthritis (a joint disease caused by cartilage loss in a joint)
  5. Osteoporosis (bones weak and more likely to break)
  6. Renal failure (kidney dysfunction)
  7. Acute respiratory failure
  8. Bone loss
  9. Bone marrow failure
  10. C-reactive protein increased

50-59:

  1. Anaemia (lack of blood)
  2. Cardiac failure

60+:

  1. Ileus (a painful obstruction of the ileum or other part of the intestine)
  2. Peritonitis (inflammation of the peritoneum, the thin tissue that lines the inner wall of the abdomen and covers most of the abdominal organs)
  3. Small intestinal perforation (hole in small intestine)

What are the existing conditions these people have? *

  1. Hiv Infection: 23 people, 41.07%
  2. Fungal Infection: 3 people, 5.36%
  3. Encephalitis Cytomegalovirus (inflammation of the brain due to cytomegalovirus): 3 people, 5.36%
  4. Bacterial Infection: 3 people, 5.36%

* Approximation only. Some reports may have incomplete information.

Do you take Mepron and Combivir?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Mepron and Combivir:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Mepron:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Combivir:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Mepron and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Combivir and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on atovaquone and lamivudine; zidovudine (the active ingredients of Mepron and Combivir, respectively), and Mepron and Combivir (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: